Internal Medicine, Medical Oncology · Scottsdale, AZ
NPI
1376561225
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7373 N Scottsdale Rd Ste E100
Scottsdale, AZ, 85253
Phone (480) 941-1211
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.3M
235,659 services
Medicare patients, 2024
432
Average age 75
Drug cost, 2024
$3.6M
1,876 prescriptions
Company payments, 2025
$707
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajinder S Grover was code J1439 (injection, ferric carboxymaltose, 1 mg), 56,250 times for 24 patients. In total Rajinder S Grover billed 235,659 services in 116 codes, and Medicare paid $4.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 56,250 | 24 | $0.87 | $49K |
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 8,360 | 37 | $0.01 | $102 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 8,184 | 11 | $20.90 | $171K |
| J0897 Injection, denosumab, 1 mg | Office | 5,100 | 17 | $20.52 | $105K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,554 | 28 | $0.09 | $227 |
| 85025 Blood Count | Office | 1,370 | 261 | $7.59 | $10K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,320 | 15 | $0.25 | $329 |
| 88185 Surgical Pathology Examination | Office | 1,242 | 36 | $15.81 | $20K |
| 36415 Venipuncture Blood Collection | Office | 1,001 | 252 | $8.64 | $8,650 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 920 | 18 | $0.77 | $707 |
| 99214 Office E&M - Established | Office | 610 | 242 | $89.59 | $55K |
| 96413 Chemotherapy Administration | Office | 553 | 50 | $97.54 | $54K |
| 99215 Office E&M - Established | Office | 509 | 108 | $133.09 | $68K |
| 96372 Injection Administration | Office | 456 | 54 | $10.92 | $4,978 |
| 96367 Intravenous Infusion, Hydration | Office | 354 | 41 | $21.47 | $7,600 |
By year: 2022 $2.5M for 159,584 services; 2023 $3.1M for 242,223 services; 2024 $4.3M for 235,659 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,370 | 261 | $7.59 | $10K |
| 88185 Surgical Pathology Examination | 1,242 | 36 | $15.81 | $20K |
| 36415 Venipuncture Blood Collection | 1,001 | 252 | $8.64 | $8,650 |
| 88184 Surgical Pathology Examination | 47 | 36 | $59.79 | $2,810 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajinder S Grover prescribed most often to Medicare patients was Eliquis (Apixaban), with 170 prescriptions and refills. In total Rajinder S Grover wrote 1,876 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 170 | 281 | 45 | $160K |
| Procrit Epoetin Alfa | 138 | 138 | 19 | $222K |
| Prednisone Generic | 118 | 143 | 38 | $620 |
| Abiraterone Acetate Generic | 70 | 70 | Under 11 | $72K |
| Acyclovir Generic | 65 | 132 | 25 | $943 |
| Xarelto Rivaroxaban | 63 | 122 | 16 | $67K |
| Anastrozole Generic | 43 | 97 | 13 | $600 |
| Fulvestrant Generic | 43 | 43 | Under 11 | $19K |
| Pantoprazole Sodium Generic | 41 | 94 | 20 | $607 |
| Xgeva Denosumab | 36 | 48 | Under 11 | $117K |
| Ondansetron Odt Ondansetron | 35 | 42 | 21 | $698 |
| Warfarin Sodium Generic | 33 | 85 | Under 11 | $343 |
| Levothyroxine Sodium Generic | 32 | 68 | Under 11 | $147 |
| Oxycodone Hcl Generic | 31 | 31 | 19 | $747 |
| Calquence Acalabrutinib Maleate | 31 | 31 | Under 11 | $319K |
Brand drugs: 735 claims; generic drugs: 1,141 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajinder S Grover $707 ($707 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $157.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $157 |
| GlaxoSmithKline, LLC. GSK | 6 | $129 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $77.31 |
| Celgene Corporation BMY | 3 | $71.64 |
| Servier Pharmaceuticals LLC | 2 | $48.03 |
| Gilead Sciences, Inc. GILD | 2 | $43.39 |
| BeiGene USA, Inc. ONC | 1 | $28.46 |
| SpringWorks Therapeutics, Inc. | 1 | $28.17 |
| Exelixis Inc. EXEL | 1 | $27.35 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $20.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.